SAN FRANCISCO, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, launches Meal Map, a new nutrient-categorization tool that combines AI-powered instant feedback with human care teams to help members in its cardiometabolic programs understand the nutrient quality of their food choices. Built within Omada’s Nutritional Intelligence capability, Meal Map is designed to help members make informed food choices, with an aim towards fostering confidence and long-term healthy habits.
In an era of increased GLP-1 use2 and rising popularity of fad diets,3 people are confused about nutrition and are seeking sustainable approaches to health beyond restrictive dieting.4 Meal Map is designed to meet this need by helping members improve their relationship with food, moving away from categorizing foods as "good" or "bad" to an evidence-based,5 nutrient-dense approach. Focusing on nutrient-density has been proven to promote broad health benefits, including supporting a robust immune system,6 boosting energy levels,7 improving digestive health,8 and reducing the risk of cardiovascular diseases such as stroke and diabetes,9 as well as certain cancers.10
In a pilot program with over 1,000 members, Meal Map demonstrated promising early results, as members showed an increase in meal engagement compared to traditional approaches.1 The tool provides instant feedback on nutrient composition of meals and delivers weekly progress reports on nutritional quality and water intake. Utilizing insights from tracked meals, members also receive recommendations for dietitian-vetted recipes through OmadaSpark, Omada's AI-powered nutrition education tool that launched earlier this year.
“This evidence-based approach fills a critical gap in the market for a tool that moves beyond simple calorie counting and food restrictions, which isn’t always necessary to lose weight;5 instead, it focuses on nutritional value and food freedom,” said Justin Wu, MD, VP of Clinical Innovation and Quality at Omada Health. “By analyzing member behavior, gathering insights from our care teams, and listening to member feedback, we’ve developed a solution that provides actionable guidance for building lasting health habits - whether members are managing cardiometabolic conditions, using GLP-1 medications, or working towards broader health goals.”
Omada Health
Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically-validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes, and musculoskeletal issues. With more than a decade of experience and data, and 30 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs. Omada’s scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s.
The foundation of Omada’s success is a strong, vibrant work culture, which helped earn the company the distinction of becoming an officially certified Great Place to Work®. An industry leader, Omada was the first virtual provider to join the Institute for Healthcare Improvement’s Leadership Alliance, reflecting the aim to complement primary care providers for the benefit of members, and affirming its guarantee to every partner: Omada works differently.
Great Place to Work® is the registered trademark of the Great Place to Work Institute and is used under license.
Contacts
Rose Ramseth
This email address is being protected from spambots. You need JavaScript enabled to view it.
September 08, 2025 August 28, 2025 August 07, 2025 |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load